{
  "meta": {
    "title": "宝锐生物营销中心销售总监 2026 年度目标责任协议书",
    "party_a": "珠海宝锐生物科技有限公司",
    "party_b": "刘新元",
    "role": "营销中心诊断原料销售部总监",
    "scope": "负责公司诊断原料和生命科学产品销售工作",
    "period": "2026-01-01 至 2026-12-31",
    "source": "用户提供的三页纸质协议照片（2026-11-09）",
    "source_images": [
      "img_d50bdaf986b5.jpg",
      "img_9336713fffac.jpg",
      "img_22d9cb2ce648.jpg"
    ],
    "note": "本文件为责任书条款结构化摘录，不替代原件；金额单位为万元。"
  },
  "sales_targets": {
    "diagnostic_industrial_normal": 6050.0,
    "life_science_normal": 900.0,
    "total_normal": 6950.0,
    "team_floor": 4170.0,
    "marketing_center_total": 9300.0
  },
  "salary_structure": {
    "formula": "年薪 = 月度固定工资 + 月度绩效奖金 + 年度绩效奖金",
    "monthly_bonus_basis": "《月度关键任务协议书》完成情况，依据《销售人员绩效管理制度》",
    "annual_bonus_basis": "年度《目标责任协议书》完成情况"
  },
  "annual_bonus_weights": {
    "key_item_diagnostic_sales": 0.5,
    "life_science_completion": 0.2,
    "marketing_center_completion": 0.1,
    "supervisor_subjective": 0.2
  },
  "coefficients": {
    "X_diagnostic": [
      {
        "range": "X≤60%",
        "coefficient": "0"
      },
      {
        "range": "60%<X≤70%",
        "coefficient": "X²"
      },
      {
        "range": "70%<X≤100%",
        "coefficient": "X"
      },
      {
        "range": "100%<X≤130%",
        "coefficient": "X²"
      },
      {
        "range": "130%<X≤175%",
        "coefficient": "X²+0.2"
      },
      {
        "range": "X>175%",
        "coefficient": "超出部分作为偶然业绩，由甲方单独确定核算方案"
      }
    ],
    "F_life_science": [
      {
        "range": "F≤60%",
        "coefficient": "0"
      },
      {
        "range": "60%<F≤100%",
        "coefficient": "F"
      },
      {
        "range": "100%<F≤130%",
        "coefficient": "F²"
      },
      {
        "range": "130%<F≤175%",
        "coefficient": "F²+0.2"
      },
      {
        "range": "F>175%",
        "coefficient": "超出部分作为偶然业绩，由甲方单独确定核算方案"
      }
    ],
    "Z_marketing_center": [
      {
        "range": "Z≤80%",
        "coefficient": 0.5
      },
      {
        "range": "80%<Z≤90%",
        "coefficient": 0.8
      },
      {
        "range": "90%<Z≤120%",
        "coefficient": 1.0
      },
      {
        "range": "Z>120%",
        "coefficient": 1.2
      }
    ],
    "subjective": [
      {
        "score": "90分以上",
        "grade": "优秀",
        "coefficient": 1.2
      },
      {
        "score": "80-90分",
        "grade": "良好",
        "coefficient": 1.0
      },
      {
        "score": "70-79分",
        "grade": "合格",
        "coefficient": 0.8
      },
      {
        "score": "60-69分",
        "grade": "不合格",
        "coefficient": 0.6
      },
      {
        "score": "60分以下",
        "grade": "差",
        "coefficient": 0
      }
    ],
    "subjective_caps": [
      "X小于90%时，主观项评分不得大于90分",
      "X小于60%时，主观项评分不得大于59分"
    ]
  },
  "annual_bonus_formula": "50%×年度绩效奖金×X1 + 20%×年度绩效奖金×F1 + 10%×年度绩效奖金×Z1 + 20%×年度绩效奖金×主观项系数；当X1为0时，F1、Z1直接为0。",
  "half_year_rule": {
    "calculation": "年度绩效奖金当年核算2次，半年度一次、年终一次；半年度按年度目标的50%核算。",
    "example": "年度目标6950万，半年度按3475万核算；上半年超过3475万的部分不核算，年终综合核算多退少补。",
    "completion_rule": "半年度未完成、年终完成年度目标的，可在年终补齐全年奖金核算总额。"
  },
  "payment_deferral": [
    {
      "overdue": "1-3个月内",
      "remaining_bonus_factor": 1.0
    },
    {
      "overdue": "3-6个月内",
      "remaining_bonus_factor": 0.8
    },
    {
      "overdue": "6-9个月内",
      "remaining_bonus_factor": 0.6
    },
    {
      "overdue": "9-12个月内",
      "remaining_bonus_factor": 0.3
    },
    {
      "overdue": "12个月以上",
      "remaining_bonus_factor": 0
    }
  ],
  "resignation_rule": "半年度/年度绩效奖金核发月份（当年7月、次年1月）前已离职的，无论业绩是否完成，未发放或未到期部分不再发放；未按规定办理离职手续或造成公司损失的，未发奖金作为损失赔偿，不足部分公司保留追偿权。",
  "red_lines": [
    "严禁索要、收取供应商、经销商、代理商、客户方财物",
    "严禁未经公司批准代理行业关联产品、合资参股行业关联公司、私自销售与公司无关产品或提供相关服务",
    "严禁骗取公司各项补贴、费用和利益",
    "严禁打听薪酬、隐私和八卦，不尊重上级领导、不执行上级工作指令",
    "严禁参与赌博、兼职和担任其他公司顾问等",
    "严禁滥用职权、徇私舞弊",
    "严禁庸政、懒政、混日子和不作为",
    "严禁私自安排亲属朋友在所辖区域工作",
    "严禁卖单、透露客户信息、产品配方、传播薪酬等公司内部文件资料",
    "严禁利用工作之便获取其它不正当利益，如样品、物料等",
    "其他违法行为"
  ],
  "open_issues": [
    {
      "issue": "生命科学部条款权重与公式文字不一致",
      "detail": "第2项标题写“生命科学销售部业绩完成率（占年度绩效奖金20%）”，但紧随其后的公式行写“大客户部销售额完成率奖金额=10%年度绩效奖金×考核系数（F1）”。",
      "suggested_action": "请HR确认是文字笔误，还是大客户部另有10%考核项；确认前不要按该行计算。"
    },
    {
      "issue": "X的分母口径未在条款中明确",
      "detail": "X定义为“诊断原料销售额完成比率”，但半年度举例用6950万减半为3475万；若X按6050万诊断原料目标、F单列生命科学900万，则半年度例子应说明是否含生命科学。",
      "suggested_action": "确认X的考核基数是6050万还是6950万；避免生命科学部业绩在X与F中重复计算。"
    }
  ],
  "relationship_to_existing_data": {
    "monthly_report_202610": "本次更新后的三部门数据看板采用总目标6950万（大客户2650+拓展3400+生命科学900），与本责任书一致。",
    "target_master_data": "数据/目标基础数据_2026.json 仍为总目标6650万、生命科学600万，尚未同步；该文件会影响看板与KPI，需确认后再统一更新。",
    "six_person_deck": "经营分析/月报/年度目标责任书达成_六人_20261108.pptx 的刘新元页仍按6650万/57.6%展示，需同步更新。"
  },
  "progress_202610": {
    "period": "2026年1-10月",
    "actual_total": 3691.9,
    "annual_target": 6950.0,
    "annual_rate": 0.531,
    "gap": 3258.1,
    "diagnostic_actual": 3651.06,
    "life_science_actual": 40.84,
    "diagnostic_rate_6050": 0.6035,
    "diagnostic_coeff_6050": 0.3642,
    "diagnostic_rate_6950": 0.531,
    "diagnostic_coeff_6950": 0.0,
    "life_science_rate": 0.0454,
    "life_science_coeff": 0.0,
    "marketing_center_rate": null,
    "marketing_center_coeff": "待补",
    "subjective": "待评",
    "bonus_coeff_ex_subjective_6050": "0.182（仅X+F，Z/主观待补）",
    "bonus_coeff_ex_subjective_6950": "0（X1为0时F1、Z1为0；主观另计）",
    "note": "X基数未确认：按诊断原料6,050万时X=60.35%、X²=0.364；按总目标6,950万时X=53.1%、X1=0。F=4.5%。营销中心Z需9,300万全口径实际，三部门实际不能直接代入，标待补。",
    "marketing_center_actual": null
  }
}